DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080)
South Korea · Delayed Price · Currency is KRW 10,410
-310 (-2.89%)
At close: Jun 12, 2026
DAE HWA Pharmaceutical Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 1,822 | 1,654 | 531.42 | -1,147 | 1,116 | 2,217 |
Depreciation & Amortization | 6,245 | 6,267 | 6,405 | 5,871 | 4,541 | 4,818 |
Loss (Gain) From Sale of Assets | - | - | - | 18.07 | 1.21 | 1.07 |
Asset Writedown & Restructuring Costs | -4,547 | -4,547 | 337 | 155 | 2,873 | 2,613 |
Loss (Gain) From Sale of Investments | -424.54 | -181.35 | 366.55 | -381.4 | 766.9 | -362.47 |
Loss (Gain) on Equity Investments | - | - | - | - | - | 212.81 |
Provision & Write-off of Bad Debts | -48.1 | -230.07 | -158.06 | 441.4 | -11.41 | 11.02 |
Other Operating Activities | 1,498 | 1,669 | 3,092 | 1,497 | 570.58 | 393.46 |
Change in Accounts Receivable | 1,473 | 3,332 | 70.05 | -5,406 | -2,433 | -537.21 |
Change in Inventory | -4,794 | -4,043 | -5,043 | -3,845 | -4,861 | 923.27 |
Change in Accounts Payable | -2,198 | 188.1 | -1,628 | 3,339 | 6,482 | 203.78 |
Change in Other Net Operating Assets | 2,233 | 1,319 | 1,277 | -756.71 | -851.72 | -108.88 |
Operating Cash Flow | 1,259 | 5,428 | 5,250 | -214.41 | 8,193 | 10,386 |
Operating Cash Flow Growth | -89.05% | 3.39% | - | - | -21.11% | 291.42% |
Capital Expenditures | -2,513 | -2,836 | -4,374 | -8,907 | -27,690 | -9,684 |
Sale of Property, Plant & Equipment | - | - | - | - | 27.34 | 1.06 |
Sale (Purchase) of Intangibles | -1,853 | -1,891 | -1,770 | -2,030 | -4,247 | -4,712 |
Investment in Securities | -892.54 | 540.48 | 10,244 | -4,311 | 6,663 | -3,277 |
Other Investing Activities | 5 | -20 | 1,170 | 29 | - | 18 |
Investing Cash Flow | -5,254 | -4,207 | 5,270 | -15,220 | -25,247 | -17,654 |
Short-Term Debt Issued | - | 81,311 | 39,850 | 66,241 | 49,303 | 47,507 |
Long-Term Debt Issued | - | 10,145 | 9,000 | 8,381 | 18,511 | 5,047 |
Total Debt Issued | 90,501 | 91,456 | 48,850 | 74,622 | 67,814 | 52,554 |
Short-Term Debt Repaid | - | -83,491 | -55,117 | -52,339 | -46,751 | -31,972 |
Long-Term Debt Repaid | - | -6,706 | -5,042 | -2,013 | -1,403 | -13,735 |
Total Debt Repaid | -79,925 | -90,197 | -60,158 | -54,353 | -48,154 | -45,707 |
Net Debt Issued (Repaid) | 10,576 | 1,259 | -11,308 | 20,270 | 19,660 | 6,848 |
Dividends Paid | -2,627 | -2,627 | -2,627 | -2,627 | -2,627 | -2,623 |
Other Financing Activities | 158.63 | 364.42 | -151.19 | -608.05 | -708.67 | 3,573 |
Financing Cash Flow | 8,107 | -1,004 | -14,087 | 17,034 | 16,324 | 7,798 |
Foreign Exchange Rate Adjustments | -523.56 | -518.16 | 876.61 | -375.86 | -147.04 | 61.21 |
Miscellaneous Cash Flow Adjustments | - | -0 | 0 | -0 | - | -0 |
Net Cash Flow | 3,588 | -301.78 | -2,691 | 1,224 | -876.6 | 591.24 |
Free Cash Flow | -1,255 | 2,591 | 875.3 | -9,122 | -19,497 | 701.81 |
Free Cash Flow Growth | - | 196.06% | - | - | - | - |
Free Cash Flow Margin | -0.88% | 1.81% | 0.59% | -6.45% | -14.78% | 0.60% |
Free Cash Flow Per Share | -71.25 | 147.83 | 49.41 | -520.75 | -1113.08 | 40.20 |
Cash Interest Paid | 4,396 | 4,517 | 5,498 | 4,495 | 2,815 | 1,342 |
Cash Income Tax Paid | 3,072 | 3,115 | -307.58 | 280.76 | 2,040 | 1,181 |
Levered Free Cash Flow | -1,565 | 2,409 | -1,953 | -10,874 | -26,251 | -10,965 |
Unlevered Free Cash Flow | 1,415 | 5,405 | 1,458 | -7,953 | -24,773 | -10,016 |
Change in Working Capital | -3,286 | 796.32 | -5,325 | -6,668 | -1,664 | 480.96 |